Here’s Why 2 Major Health Centers Won’t Carry Controversial New Alzheimer’s Drug

The FDA approved Aduhelm last month, but the treatment remains controversial.

Source: https://www.forbes.com/sites/carlieporterfield/2021/07/15/heres-why-2-major-health-centers-wont-carry-controversial-new-alzheimers-drug/

Join the Discussion

  • BrokerEUR/USD
    CMC Markets 0.7pips. (variable) margin: 3.33%
    OANDA 1.3pips (variable) margin: 3.33%
  • Back to top